UPDATE
UPDATES from DIA 2012: "Collaborate to innovate," says the association
On Monday organisation opened the doors to its conference, and already Twitter has been flooded with news and views about drug development and how the DIA (Drug Information Association) is involved.
As always, the need for more innovation is a crucial issue, and better trial management systems is also a subject close to many’s hearts, with ethics in emerging markets, IRBs (institutional review boards), and paediatrics as some of the big topics.
Outsourcing-Pharma.com presents the cream of the crop as the show goes on…
